SYNLAB AG
A leading provider of medical & veterinary diagnostic services for diverse clients worldwide.
SYAB | F
Overview
Corporate Details
- ISIN(s):
- DE000A2TSL71
- LEI:
- 984500883BA5AQ14C037
- Country:
- Germany
- Address:
- Moosacher Straße 88, 80809 München
- Website:
- https://www.synlab.com/
- Sector:
- Human health and social work activities
- Industry:
- Other residential care activities
Description
SYNLAB AG is a leading European provider of medical diagnostic services and specialty testing. The company offers a comprehensive portfolio of innovative and reliable laboratory diagnostics to a diverse clientele, including patients, practicing doctors, hospitals, clinics, governments, and corporations. Its services are integral to patient care, supporting clinical decision-making across prevention, diagnosis, treatment, and disease monitoring. Operating on four continents, SYNLAB leverages a network of over 2,000 medical experts and more than 1,800 blood collection points to deliver its services. The company also provides diagnostic solutions for veterinary medicine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-23 09:00 |
Regulatory News Service
Further investment in Italy to provide cutting-edge diagnostics and patient exp…
|
English | 7.6 KB | ||
| 2025-10-09 15:00 |
Regulatory News Service
SYNLAB expands investment in Italy with opening of flagship Medical Centre in F…
|
English | 6.8 KB | ||
| 2025-07-31 00:00 |
Legal Proceedings Report
Datum:31.07.2025
|
German | 28.6 KB | ||
| 2025-07-31 00:00 |
Legal Proceedings Report
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2023 bis zum 30.06.2023
|
German | 17.8 KB | ||
| 2025-07-22 09:00 |
Regulatory News Service
Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk
|
English | 9.9 KB | ||
| 2025-07-01 09:00 |
Environmental & Social Information
Milestone Reached in Groundbreaking Project for Early Detection of Parkinsons D…
|
English | 11.3 KB | ||
| 2024-10-30 07:32 |
Share Issue/Capital Change
Cinven to Acquire Elliotts Stake in SYNLAB AG, Squeeze-Out to Follow
|
English | 12.5 KB | ||
| 2024-09-17 16:00 |
M&A Activity
Cinven to sell minority stake in SYNLAB to strategic investor Labcorp
|
English | 20.5 KB | ||
| 2024-06-04 20:46 |
Legal Proceedings Report
Cybersecurity Incident at Synnovis in UK
|
English | 10.1 KB | ||
| 2024-05-31 08:40 |
Delisting Announcement
SYNLAB AG: Cinven announces public delisting acquisition offer | Conclusion of …
|
English | 6.0 KB | ||
| 2024-05-13 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2024
|
English | 547.7 KB | ||
| 2024-05-08 07:00 |
Earnings Release
SYNLAB delivers strong performance in Q1 2024
|
English | 40.9 KB | ||
| 2024-04-30 14:56 |
Legal Proceedings Report
SYNLAB Italy has restored operations after cyber-attack
|
English | 10.2 KB | ||
| 2024-04-23 11:12 |
Major Shareholding Notification
|
English | 13.2 KB | ||
| 2024-04-22 10:42 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 13.8 KB |
Automate Your Workflow. Get a real-time feed of all SYNLAB AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SYNLAB AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SYNLAB AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-10-02 | Ebsworth GmbH | Close relation | Sell | None | 107,484.01 EUR |
| 2023-10-02 | Ebsworth GmbH | Close relation | Sell | None | 7,140.00 EUR |
| 2022-05-10 | Henkel, Dr. Holger | Supervisory board | Other | None | N/A |
| 2022-05-04 | Riedel, Oliver | Board | Buy | None | 5,800.00 EUR |
| 2022-05-02 | Schmitt, Martin | Supervisory board | Buy | None | 1,071.00 EUR |
| 2021-12-21 | Lorenz-Meyer, Robert | Supervisory board | Sell | None | 8,960.90 EUR |
Peer Companies
